Bioengineering Alumna Awarded Soros Fellowship for New Americans
As an undergraduate at UC San Diego, Al Msari conducted research at Moores Cancer Center in the labs of Joseph Califano, MD and J. Silvio Gutkind, PhD., where she studied the important role of tumor-draining lymph nodes in head and neck cancers. Her research (1) contributed to a clinical shift toward lymphatics-preserving neoadjuvant immunotherapies and (2) resulted in her co-authorship on several papers. It also extended to creating a tissue-engineered lymph node for her capstone bioengineering senior design project, which restored immune functionality lost in standard cancer treatments.
|
UC San Diego Researchers Honored as Prebys Research Heroes
Three UC San Diego researchers have been named Prebys Research Heroes by the San Diego-based Conrad Prebys Foundation. Moores Member Stephanie Fraley, PhD, is a part of this group of researchers who received grants of $500,000 each to support research that advances health care and medical discoveries.
|
17th American Association for Cancer Research (AACR) Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
September 21–24, 2024, The Westin Bonaventure Hotel & Suites, Los Angeles, CA
Explore cutting-edge research on cancer disparities at the 17th AACR Conference. Submit an abstract by June 6, 2024 to present your research to experts from academia, industry, government, and the community to exchange ideas, discuss findings, and drive new research initiatives toward eliminating cancer disparities and promoting health equity.
|
Important to Complete: Moores Climate Survey |
Please check your email inbox for an email with the subject Important to Complete: Moores Cancer Center Climate Survey, which contains a unique link to the survey. You also can complete the survey using QR codes that you may see posted in Moores. Please take less than 5 minutes and share your voice!
|
Moores Office of Equity, Diversity, and Inclusion (EDI) Pop-Ups |
Moores Office of EDI hopes that you have been enjoying the Pop-Ups around Moores this week and last, and is excited to announce the first round of winners.
Post-Survey Sign-Up Drawing (Remote Moores Members can enter to win)
Congratulations! Connie Sherwood is our Moores Climate Survey winner for the online prize of week 1. She wins a $150 gift card!
In-Person Pop-Up Drawing (Must visit a Pop-Up in person to enter)
Congratulations! Jennie Duong and Lien Ly are the Pop-Up winners! They each win a gift card for $30!
Winners–the Office of EDI will be in touch via email 🙂.
If you did not win, do not worry! Your entries for both drawings remain in the running. Please visit the future Pop-Ups happening through May 17, 2024 for more chances to win and pick-up treats and Moores goodies as well.
In addition, there are more chances to win online and in-person. Just complete the survey, if you have not, or visit a Pop-Up–locations for these are secret and released the day of the event.
Here are the dates for the upcoming Pop-Ups:
Pop-Up 3—Wednesday, May 8, 2024
Pop-Up 4—Monday, May 13, 2024
Pop-Up 5—Wednesday, May 15, 2024
Pop-Up 6—Friday, May 17, 2024 (Moores Climate Survey closes)
Email the Moores Office of EDI at mcc_edi@health.ucsd.edu for questions.
|
|
|
May 7, 2024 | 12:00 p.m.
Leichtag Biomedical Research Building Room 107
|
May 8, 2024 | 12:00 p.m.
Leichtag Biomedical Research Building Room 107
|
May 10, 2024 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons
|
May 15, 2024 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons
|
| |
Moores Cancer Center Speed Mentoring Workshop |
Thursday, May 9, 2023 | 1:00 p.m. to 2:00 p.m. |
Trust in Cancer Care: Advancing Equity and Trustworthiness |
May 30, 2024 | 2:00 p.m. to 3:00 p.m. ET |
Although trust in healthcare is essential for optimal cancer care and outcomes, current efforts to measure and improve trust and trustworthiness in healthcare often target patients, rather than improving the healthcare system. In this webinar, two invited experts will present on the constructs of trust and trustworthiness in the context of cancer care. Dr. Andrew Anderson will present key definitions and conceptual frameworks on trust and related constructs and offer guidance on how best to measure these constructs. Dr. Jennifer Richmond will present on how trust affects healthcare use and cancer outcomes and provide recommendations for building trust and institutional trustworthiness to advance health equity.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
NIH Resubmission Guideline Changes |
Effective May 25, 2024, the use of markup, such as bracketing, indenting, highlighting, bolding, italicizing, underlining, margin lines, change in typography, font, or font color, or any other type of markup should not be used to identify changes in resubmission applications.
|
Changes made to a resubmission application should be outlined only in the Introduction attachment, which must include (1) a summary of substantial additions, deletions, and changes to the application and (2) a response to weaknesses raised in the Summary Statement. Unless otherwise indicated in the Table of Page Limits, the Introduction may not exceed one page.
|
Cancer Research Education Grants Program—Courses for Skills Development (R25 Clinical Trial Not Allowed) |
This NCI R25 program supports champions activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs. This notice of funding opportunity (NOFO) will support creative educational activities that target courses for skills development.
|
Next Deadline: May 25, 2024 (Standard NIH Due Dates Apply)
|
Cancer Research Education Grants Program—Research Experiences (R25 Clinical Trial Not Allowed) |
This NCI R25 program supports champions activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs. This NOFO will support creative educational activities that target research experiences.
|
Next Deadline: May 25, 2024 (Standard NIH Due Dates Apply)
|
Cancer Research Education Grants Program—Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
This NCI R25 program supports champions activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs. This NOFO will support creative educational activities that target curriculum or methods development.
|
Next Deadline: May 25, 2024 (Standard NIH Due Dates Apply)
|
|
|
|
Phase II trial of cisplatin, gemcitabine, and intensity-modulated radiation therapy for locally advanced vulvar squamous cell carcinoma: NRG Oncology/GOG Study 279 |
Journal of Clinical Oncology
|
Jyoti Mayadev, MD (Solid Tumor Therapeutics)
|
|
|
| Measurement of ctDNA tumor fraction identifies informative negative liquid biopsy results and informs value of tissue confirmation |
Hatim Husain, MD (Structural and Functional Genomics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
INB-400: A Phase Ib/II Open-label Study to Investigate the Safety, Tolerance and Efficacy of Drug Resistant Immunotherapy (DRI) with Activated, Gene Modified Allogeneic or Autologous T Cells (Delt-Ex) in Combination with Maintenance Temozolomide (TMZ) in Subjects with Recurrent or Newly Diagnosed Glioblastoma |
PI: David Piccioni, MD, PhD
NCT: NCT05664243
|
Olvi-Vec-022: A Randomized Phase III Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women with Platinum-Resistant/Refractory Ovarian Cancer (On-Prime, GOG3076) |
PI: Michael McHale, MD
NCT: NCT05281471
|
NXP800-101: A Phase I Clinical Study of NXP800 in Subjects with Advanced Cancers and Expansion in Subjects with Ovarian Cancer |
PI: Ramez Eskander, MD
NCT: NCT05226507
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT |
|
|
Border Health Consortium in the South Bay |
COE was honored to represent the Moores Cancer Center at the recent Border Health Consortium in the South Bay. Moores Member, Jesse Nodora, DrPH, lead of the cancer workgroup, delivered a presentation on cancer disparities in the San Diego-Baja area, emphasizing the vision for cross-border collaboration. COE is proud to support initiatives that address cancer disparities in the Moores catchment area.
|
Jackie Robinson YMCA Health Fair |
COE attended the Jackie Robinson YMCA Health Fair and shared cancer prevention resources and education with attendees, engaging in over 80 tabling conversations. If you would like to join our team at the next health fair, then email COE at mcccoe@health.ucsd.edu.
|
San Diego County Promotores Coalition (SDCPC) Collaborative Meetings |
COE, alongside colleagues from the Center for Health Equity and Education (CHEER) at the UC San Diego, School of Medicine, have been engaged with the SDCPC to promote the upcoming Promotores Advisory Board, which will integrate the voices of community health workers with those of Moores by facilitating a bi-directional conversation to ensure the sustainability of community-academic partnerships and uplifting partnered research.
|
|
|
|
